COSTAR: Improved Temporal Counterfactual Estimation with Self-Supervised Learning
Meng, Chuizheng, Dong, Yihe, Arık, Sercan Ö., Liu, Yan, Pfister, Tomas
–arXiv.org Artificial Intelligence
Accurate estimation of treatment outcomes over time conditioning on the observed history is a fundamental problem in causal analysis and decision making in various applications (Mahar et al., 2021; Ye et al., 2023; Wang et al., 2023). For example, in medical domains, doctors are interested in knowing how a patient reacts to a treatment or multi-step treatments; in e-commerce, retailers are concerned about how future sales change if adjusting the price of an item. While randomized controlled trials (RCTs) are the gold standard for treatment outcome estimation, most often than not such trials are either too costly or even impractical to conduct. Therefore, utilizing available observed data (such as electronic health records (EHRs) and historical sales) for accurate treatment outcome estimation, has drawn increasing interest in the community. Compared to the well-studied i.i.d cases, treatment outcome estimation from time series observations not only finds more applications in the real world but also pose significant more challenges, due to the complex dynamics and the long-range dependencies in time series. Existing works along this endeavors explore various architectures with improved capacity and training strategies to alleviate time-dependent confounding. Recurrent marginal structural networks (RMSNs) (Lim, 2018), counterfactual recurrent networks (CRN) (Bica et al., 2020), and G-Net (Li et al., 2021) utilize architectures based on recurrent neural networks. To mitigate time-dependent confounding, they train proposed models with inverse probability of treatment weighting (IPTW), treatment invariant representation through gradient reversal, and G-computation respectively, in addition to the factual estimation loss on observed data. Causal Transformer (CT) (Melnychuk et al., 2022) further improves capturing long-range dependencies in the observational data
arXiv.org Artificial Intelligence
Nov-1-2023
- Country:
- North America > United States > California (0.14)
- Genre:
- Research Report
- Strength High (1.00)
- Experimental Study (1.00)
- Research Report
- Industry:
- Health & Medicine > Therapeutic Area > Oncology (1.00)
- Technology: